Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Omega Diagnostics Group Plc (ODX) Ord 4p

Sell:79.00p Buy:80.00p 0 Change: 1.50p (1.92%)
Market closed Prices as at close on 25 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 1.50p (1.92%)
Market closed Prices as at close on 25 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 1.50p (1.92%)
Market closed Prices as at close on 25 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.

Contact details

Omega House
Hillfoots Business Village, Scotland
FK12 5DQ
United Kingdom
+44 (01259) 763030

Important dates

Future events
There are no future events available.
Past events
AGM 26 August 2020 26/08/20
Annual report 23 July 2020 23/07/20
Final results 14 July 2020 14/07/20
General meeting 10 July 2020 10/07/20
Trading Announcement 09 June 2020 09/06/20
Trading Announcement 20 April 2020 20/04/20
Trading Announcement 02 April 2020 02/04/20
Interim results 02 December 2019 02/12/19
Trading Announcement 22 October 2019 22/10/19
AGM 22 October 2019 22/10/19
General meeting 10 October 2019 10/10/19

General stock information

Market cap:
£142.05 million
Shares in issue:
178.68 million
Health Care Equipment & Services
London Stock Exchange
Sterling pence

Key personnel

  • Colin King
    Chief Executive Officer, Chief Operating Officer, Director
  • Kieron Harbinson
    Group Finance Director, Company Secretary, Executive Director
  • Iain Logan
    Group Financial Controller
  • Jag Grewal
    Group Sales and Marketing Director, Executive Director
  • Karsten Brenzke
    Site Manager of Omega Diagnostics GmbH
  • Mike Gordon
    Group Operations Director
  • Prashant Maniar
    Managing Director of Omega Dx (Asia) Pvt Limited
  • Edward Valente
    Group Research and Development Director
  • Jamie Yexley
    Site Manager of Genesis Diagnostics Limited and Cambridge Nutritional Sciences Limited

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.